scispace - formally typeset
Z

Zelihagül Değim

Researcher at Gazi University

Publications -  32
Citations -  999

Zelihagül Değim is an academic researcher from Gazi University. The author has contributed to research in topics: Liposome & Insulin. The author has an hindex of 14, co-authored 32 publications receiving 858 citations. Previous affiliations of Zelihagül Değim include Cardiff University.

Papers
More filters
Journal ArticleDOI

An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor.

TL;DR: It can be concluded that a better and faster epithelization was observed in the EJ group compared to the other groups, and to determine the effect on healing of second-degree burn wounds in rats.
Journal ArticleDOI

An investigation on skin wound healing in mice with a taurine-chitosan gel formulation.

TL;DR: It was found that locally administered TAU-GEL form significantly increased wound tensile strength by decreasing the MDA and increasing HPX levels, and these results were supported by histological findings.
Journal ArticleDOI

Evaluation of chitosan gel containing liposome‐loaded epidermal growth factor on burn wound healing

TL;DR: A chitosan gel formulation containing liposomes loaded with epidermal growth factor (EGF) was developed and their effects on the healing of second‐degree burn wounds in rats were evaluated by immunohistochemical, histochemical and histological methods.
Journal ArticleDOI

The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer

TL;DR: The permeability of insulin was increased across Caco-2 cell monolayer when the liposome sodium taurocholate (NaTC) formulation was used and the oral administration of insulin and NaTC incorporated liposomes significantly decreased blood glucose levels.
Journal ArticleDOI

Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing.

TL;DR: It was observed that the healing in the ELP group was the fastest among all groups (p < 0.05) at the 14th day of therapy.